CEO Talks: Innovators Combating Drug Resistance

Published on :

BioBuzz has partnered with Wilson Sonsini Goodrich & Rosati for the second installment of the #CEOTalks event series. This event will bring you insights from local company executives on the game-changing technologies they are bringing to market to address one of the greatest public health threats of our age; multi-drug resistant bacteria and other infectious agents. However, bringing [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Carol Nacy, Ph.D.
Published on :

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance  For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all started with a fascination for things unseen. “At Catholic University a few wonderful biology professors introduced me to this amazing world of invisible life that [….]